title: Cell-free HIV-1Zr6 vif mutants are defective in binding to peripheral blood mononuclear cells and in internalization.
abstract: The vif gene of the human immunodeficiency virus (HIV-1) is required for productive virus infection of primary blood mononuclear cells (PBMCs) and macrophages in vitro. Replication of HIV-1 vif- mutants in T-lymphoid cell lines varies and is dependent on the cell line used for virus production. To further understand the role of Vif in HIV-1 infection, we constructed to vif deletion mutants from a molecular clone derived from an African patient (HIV-1Zr6). Cell-free Zr6 vif- virus pools made from transfected rhabdomyosarcoma (RD) cells do not replicate when added to cultures of stimulated PBMCs. However, vif mutants were able to spread from transfected RD cells to PBMCs if cell-to-cell contact was permitted. By Western blot analysis, viral structural proteins expressed after transfection of RD cells by wild-type or vif mutant proviruses were indistinguishable. However, binding of vif mutants to PBMCs or to purified CD4 and virus internalization were significantly reduced when compared with wild-type virus. The defects in cell-free infection, CD4 binding, and internalization were rescued by transcomplementation using a vif expression plasmid. Our results suggest a novel level at which the HIV-1 vif gene product acts to enhance cell-free infection and indicate that vif plays an important role in promoting HIV-1 binding and internalization. Combined with the previous reports of vif's effect at other steps in infection, this suggests that vif is a pleuripotent gene product that affects multiple stages of the infective process.
authors.affiliation: Department of Medicine, University of Pennsylvania, Philadelphia 19104-6073, USA.
authors.forename: T
authors.initials: T
authors.lastname: Nagashunmugam
authors.forename: H M
authors.initials: HM
authors.lastname: Friedman
mesh_terms: D015704:CD4 Antigens / Q000378:metabolism; D002461:Cell Line, Transformed; D002478:Cells, Cultured; D004279:DNA, Viral / Q000032:analysis; D015686:Gene Products, env / Q000032:analysis; D016341:Genes, vif / Q000502:physiology*; D005816:Genetic Complementation Test; D015497:HIV-1 / Q000235:genetics / Q000378:metabolism / Q000472:pathogenicity* / Q000502:physiology; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000821:virology*; D009154:Mutation; D010641:Phenotype; D012208:Rhabdomyosarcoma; D013601:T-Lymphocytes; D014407:Tumor Cells, Cultured; D014779:Virus Replication
chemical_list: D015704:CD4 Antigens; D004279:DNA, Viral; D015686:Gene Products, env